Medway NHS Foundation Trust is looking to make rapid improvements in its digital maturity with the Allscripts Sunrise electronic patient record.
The Kent trust signed a contract with Allscripts in December 2020 and is planning to go-live with the first phase of core functionality six months from the start of the project.
Siemens Healthineers and the Kantonsspital Baden (KSB) in Switzerland, a networked, regional center of competence, have formed a long-term, strategic and technological partnership for the next eight years. This "Value Partnership" includes procurement and maintenance of medical imaging systems, holistic technology management with guaranteed uptime, expansion of telemedicine solutions, technology needs and capacity assessment, process optimization, and certified employee training programs. 
British health technology company Visionable has announced the appointment of David Walker to the newly created position of Chief Commercial Officer (CCO), effective immediately. Visionable redesigns healthcare through a digital collaboration platform which enables clinicians to deliver better patient outcomes. 
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced that it has completed the acquisition of BioTelemetry, Inc. (NASDAQ: BEAT), a leading U.S.-based provider of remote cardiac diagnostics and monitoring. BioTelemetry’s financial results will be consolidated as part of Philips’ Connected Care business segment as of February 9, 2021. 
A senior nurse with more than 20 years' experience in the NHS has joined smart health tech provider Alcidion in a core role as a clinical consultant primarily working with the UK team.
Katy Cain joins Alcidion from East Lancashire Hospitals NHS Trust, where she held a wide range of posts in clinical roles, most recently as a modern matron for the trust’s cardiology directorate.
Royal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, announced that it has successfully completed its previously announced tender offer (the "Offer") to purchase all outstanding shares of BioTelemetry, Inc. (NASDAQ: BEAT), a leading U.S.-based provider of remote cardiac diagnostics and monitoring for USD 72.00 per share in cash. 
Royal Bolton NHS Foundation Trust has been much praised for its deployment of AI in the fight against Covid-19. Rizwan Malik, divisional medical director of the trust and managing director of South Manchester radiology, spoke to the Highland Marketing advisory board about the project and the lessons that other trusts can learn from it.